Company: SNPS
Filing Date: 2025-07-17
Form Type: 8-K
Source: 0001140361-25-026139
Chunk: 6

Company: SYNOPSYS INC
Filing Date: 2025-07-17
Form: 8-K
Item: Item 5.02
Chunk 6
---
 to such program, Dr. Gopal and Mr.
Vijayaraghavan will each receive an annual cash retainer of $125,000, which is payable in advance in four equal payments prior to Synopsys’ regularly scheduled quarterly Board meetings and will be prorated in their first year of service. Further, Dr.
Gopal and Mr. Vijayaraghavan will receive (i) an initial restricted stock award for shares of Synopsys common stock with a grant date fair market value of $350,000, which will vest in equal installments on the date immediately preceding each of the
first three annual meetings following the date of grant, subject to continued Board service through each vesting date; and (ii) an interim restricted stock award for shares of Synopsys common stock with a grant date fair market value equal to a
prorated portion of the annual award of $200,000, which will vest on the date immediately preceding the first annual meeting following the date of grant.

Neither Dr. Gopal nor Mr. Vijayaraghavan have any family relationship with any of Synopsys’ directors or executive officers or any persons nominated or
chosen by Synopsys to be a director or executive officer. Furthermore, neither Dr. Gopal nor Mr. Vijayaraghavan have any direct or indirect material interest in any transaction or proposed transaction required to be reported under Section 404(a) of
Regulation S-K other than consideration received in connection with the Merger in accordance with the terms of the Merger Agreement.

In accordance with Synopsys’ customary practice, Synopsys is entering into its standard form of indemnification agreement with each of Dr. Gopal and Mr.
Vijayaraghavan, which requires Synopsys to indemnify Dr. Gopal and Mr. Vijayaraghavan against certain liabilities that may arise as result of their status or service as directors. The description of Dr. Gopal’s and Mr. Vijayaraghavan’s
indemnification agreements is qualified in its entirety by the full text of the form of indemnification agreement, which is attached to Synopsys’ Form 8-K filed on July 14, 2011, as Exhibit 99.2.

In connection with the Merger, immediately following the Effective Time, Janet Lee, Senior Vice President, General Counsel and Secretary
of Ansys was appointed as Synopsys’ General Counsel and Corporate Secretary, succeeding John F. Runkel, Jr. in these positions. Mr